Earnings History Data for Agile Therapeutics, Inc. (AGRX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Agile Therapeutics, Inc.

Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. It is focused on the development and commercialization of new prescription contraceptive products. The Company's lead product candidate is Twirla (TM), also known as AG200-15, a once-weekly prescription contraceptive patch currently in Phase 3 clinical development. Agile Therapeutics, Inc. is headquartered in Princeton, New Jersey.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
09-11-2023	PM		AGRX	Agile Therapeutics, Inc.	3.87	-1.47	0.00	-11.50	Agile Therapeutics Non-GAAP EPS of -$1.47 beats by $0.37, revenue of $6.66M beats by $0.31M [11/9/2023 8:12 AM]	1.99	0.01 (0.51%)	2.25	0.27 (13.64%)	1.65 - 16.00	52,739	30,000	1,035
Agile Therapeutics Q3 2023 Earnings Preview [11/8/2023 12:18 PM] Agile Therapeutics Non-GAAP EPS of -$1.47 beats by $0.37, revenue of $6.66M beats by $0.31M [11/9/2023 8:12 AM]
09-08-2023	PM		AGRX	Agile Therapeutics, Inc.	2.62	-3.10	-3.48	-99.99	Agile Therapeutics Non-GAAP EPS of -$3.10 beats by $1.85, revenue of $5.5M beats by $0.87M [8/9/2023 8:14 AM]	2.31	-0.28 (-10.81%)	2.75	0.16 (6.18%)	2.20 - 38.50	142,156	40,000	19,383
Agile Therapeutics Q2 2023 Earnings Preview [8/8/2023 2:25 PM] Agile Therapeutics Non-GAAP EPS of -$3.10 beats by $1.85, revenue of $5.5M beats by $0.87M [8/9/2023 8:14 AM]
11-05-2023	AH	4:05 PM ET (May 11)	AGRX	Agile Therapeutics, Inc.	5.71	-7.76	0.00	-99.99	Agile Therapeutics GAAP EPS of -$5.91 beats by $1.59, revenue of $3.81M beats by $0.41M [5/11/2023 4:07 PM]	4.96	-0.72 (-12.68%)	0.0	0.0 (0.00%)	4.88 - 140.99	58,852	30,000	0
Agile Therapeutics GAAP EPS of -$5.91 beats by $1.59, revenue of $3.81M beats by $0.41M [5/11/2023 4:07 PM]
22-03-2023	AH	4:05 PM ET (Mar 22)	AGRX	Agile Therapeutics, Inc.	11.87	-0.18	-0.21	8.00	Agile Therapeutics GAAP EPS of -$0.10 beats by $0.12, revenue of $4M beats by $0.87M [3/22/2023 4:53 PM]	0.2420	-0.02 (-9.33%)	0.27	0.0 (0.22%)	0.17 - 11.40	1,806,430	800,000	483,664
Agile Therapeutics GAAP EPS of -$0.10 beats by $0.12, revenue of $4M beats by $0.87M [3/22/2023 4:53 PM]
07-11-2022	AH	4:05 PM ET (Nov 7)	AGRX	Agile Therapeutics, Inc.	10.81	-0.23	-0.30	-7.20	Agile Therapeutics GAAP EPS of -$0.53 misses by $0.23, revenue of $3M beats by $0.67M [11/7/2022 4:13 PM]	0.2550	-0.06 (-20.06%)	0.29	-0.03 (-9.09%)	0.25 - 31.66	2,497,583	1,210,000	40,057
Agile Therapeutics GAAP EPS of -$0.53 misses by $0.23, revenue of $3M beats by $0.67M [11/7/2022 4:13 PM] Agile Therapeutics stock falls ~17% following mixed Q3 results [11/8/2022 12:56 PM] Agile Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update [Nov-07-22 04:05PM]
11-08-2022	AH	4:05 PM ET (Aug 11)	AGRX	Agile Therapeutics, Inc.	17.03	-2.71	0.00	8.00	Agile Therapeutics GAAP EPS of -$2.71 beats by $0.99, revenue of $2.1M beats by $0.12M [8/11/2022 4:22 PM]	0.5648	-0.08 (-11.96%)	0.60	-0.05 (-7.25%)	0.49 - 50.40	5,470,692	5,880,000	398,772
Agile Therapeutics GAAP EPS of -$2.71 beats by $0.99, revenue of $2.1M beats by $0.12M [8/11/2022 4:22 PM] Agile Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update [Aug-11-22 04:05PM] Agile Therapeutics (AGRX) Q2 2022 Earnings Call Transcript [Aug-11-22 09:30PM]
12-05-2022	AH	4:05 PM ET (May 12)	AGRX	Agile Therapeutics, Inc.	6.57	-3.78	0.00	8.00	Agile Therapeutics GAAP EPS of -$3.78 beats by $2.22, revenue of $1.76M beats by $0.54M [5/12/2022 4:11 PM]	1.61	-0.04 (-2.12%)	1.64	-0.01 (-0.61%)	1.58 - 69.60	227,164	480,000	8,170
Agile Therapeutics GAAP EPS of -$3.78 beats by $2.22, revenue of $1.76M beats by $0.54M [5/12/2022 4:11 PM] Agile Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update [May-12-22 04:05PM] Agile Therapeutics (AGRX) Q1 2022 Earnings Call Transcript [May-13-22 12:00AM]
30-03-2022	AH	4:05 PM ET (Mar 30)	AGRX	Agile Therapeutics, Inc.	31.85	-0.20	-0.17	-0.20	Agile Therapeutics GAAP EPS of -$0.20, revenue of $1.51M [3/30/2022 4:10 PM]	0.2110	-0.03 (-12.05%)	0.23	-0.01 (-3.21%)	0.20 - 2.21	7,005,725	2,120,000	250,002
Agile Therapeutics GAAP EPS of -$0.20, revenue of $1.51M [3/30/2022 4:10 PM] Agile Therapeutics stock slumps 10% following Q4 results [3/31/2022 12:03 PM] Agile Therapeutics (AGRX) Reports Q4 Loss, Misses Revenue Estimates [Mar-30-22 05:25PM] Agile Therapeutics Reports Fourth Quarter & Full Year 2021 Financial Results and Provides Corporate Update [Mar-30-22 04:05PM] Agile Therapeutics (AGRX) Q4 2021 Earnings Call Transcript [Mar-30-22 11:00PM] Agile Therapeutics® Announces First Twirla® Commercial Targeting Gen Z [Mar-31-22 07:30AM]
02-11-2021	AH	4:05 PM ET (Nov 2)	AGRX	Agile Therapeutics, Inc.	95.12	-0.18	-0.19	-0.18	Agile Therapeutics EPS beats by $0.01, misses on revenue [11/2/2021 4:11 PM]	0.7993	-0.06 (-7.06%)	0.79	-0.07 (-8.14%)	0.66 - 3.77	1,219,440	1,570,000	180,512
Agile Therapeutics EPS beats by $0.01, misses on revenue [11/2/2021 4:11 PM] Agile Therapeutics Reports Third Quarter 2021 Financial Results [Nov-02-21 04:05PM] Agile Therapeutics (AGRX) Reports Q3 Loss, Lags Revenue Estimates [Nov-02-21 06:45PM]
26-07-2021	AH	4:05 PM ET (Jul 26)	AGRX	Agile Therapeutics, Inc.	106.80	-0.20	-0.21	-0.12	Agile Therapeutics EPS beats by $0.01, misses on revenue [7/26/2021 4:11 PM]	1.11	-0.01 (-0.89%)	1.12	0.0 (0.00%)	1.02 - 3.89	1,178,896	720,000	42,072
Agile Therapeutics EPS beats by $0.01, misses on revenue [7/26/2021 4:11 PM] Agile Therapeutics Q2 2021 net loss widens as marketing expenses grow [7/26/2021 4:43 PM] Agile Therapeutics Reports Second Quarter 2021 Financial Results [Jul-26-21 04:05PM] Agile Therapeutics (AGRX) Reports Q2 Loss, Lags Revenue Estimates [Jul-26-21 05:55PM] Agile Therapeutics (AGRX) Q2 2021 Earnings Call Transcript [Jul-27-21 01:30AM]
04-05-2021	AH	4:05 PM ET (May 4)	AGRX	Agile Therapeutics, Inc.	160.64	-0.20	-0.22	-0.10	Agile Therapeutics EPS beats by $0.01 [5/4/2021 4:24 PM]	1.50	-0.21 (-12.24%)	1.68	-0.04 (-2.04%)	1.42 - 3.89	3,887,683	920,000	40,448
Agile Therapeutics EPS beats by $0.01 [5/4/2021 4:24 PM] Agile Therapeutics, Inc. to Host Earnings Call [May-04-21 02:30PM] Agile Therapeutics Reports First Quarter 2021 Financial Results [May-04-21 04:05PM] Agile Therapeutics (AGRX) Reports Q1 Loss, Lags Revenue Estimates [May-04-21 07:15PM] Agile Therapeutics (AGRX) Q1 2021 Earnings Call Transcript [May-05-21 08:01AM]
01-03-2021	AH	4:05 PM ET (Mar 1)	AGRX	Agile Therapeutics, Inc.	266.30	-0.20	-0.23	-0.10	Agile Therapeutics EPS beats by $0.03, misses on revenue [3/1/2021 4:08 PM]	2.62	-0.40 (-13.24%)	2.88	-0.14 (-4.64%)	1.35 - 3.89	4,221,229	1,246,148	41,669
Agile Therapeutics EPS beats by $0.03, misses on revenue [3/1/2021 4:08 PM] Agile Therapeutics (AGRX) Reports Q4 Loss, Misses Revenue Estimates [Mar-01-21 06:15PM] Agile Therapeutics Reports Fourth Quarter & Full Year 2020 Financial Results; Expands Loan Facility With Perceptive Advisors [Mar-01-21 04:05PM]
12-11-2020	AH	4:00 PM ET (Nov 12)	AGRX	Agile Therapeutics, Inc.	254.43	-0.18	-0.18	-0.08	Agile Therapeutics EPS in-line [11/12/2020 4:12 PM]	2.86	-0.06 (-1.88%)	2.92	0.0 (0.00%)	1.35 - 4.77	1,101,412	727,491	2,855

11-08-2020	AH	4:00 PM ET (Aug 11)	AGRX	Agile Therapeutics, Inc.	231.12	-0.12	-0.13	-0.08	Agile Therapeutics EPS beats by $0.02 [8/11/2020 4:05 PM]	2.51	-0.08 (-3.09%)	2.66	0.07 (2.70%)	0.35 - 4.77	997,642	1,083,152	47,205

05-05-2020	AH	4:00 PM ET (May 5)	AGRX	Agile Therapeutics, Inc.	241.58	-0.10	-0.09	-0.13	Agile Therapeutics EPS misses by $0.01 [5/5/2020 4:05 PM]	2.83	0.07 (2.54%)	2.50	-0.33 (-11.67%)	0.35 - 4.77	3,867,182	3,016,042	68,541